Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

BACKGROUND: Well-differentiated neuroendocrine carcinomas are highly vascularized and may be sensitive to drugs administered on a metronomic schedule that has shown antiangiogenic properties. A phase II study was designed to test the activity of protracted 5-fluorouracil (5FU) infusion plus long-act...

Descripción completa

Detalles Bibliográficos
Autores principales: Brizzi, Maria P, Berruti, Alfredo, Ferrero, Anna, Milanesi, Enrica, Volante, Marco, Castiglione, Federico, Birocco, Nadia, Bombaci, Sebastiano, Perroni, Davide, Ferretti, Benedetta, Alabiso, Oscar, Ciuffreda, Libero, Bertetto, Oscar, Papotti, Mauro, Dogliotti, Luigi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776604/
https://www.ncbi.nlm.nih.gov/pubmed/19886987
http://dx.doi.org/10.1186/1471-2407-9-388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776604/
https://www.ncbi.nlm.nih.gov/pubmed/19886987
http://dx.doi.org/10.1186/1471-2407-9-388

Ejemplares similares